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Background
Chronic progressive multisystem granulomatous disease is
seen in 10–30% of patients with sarcoidosis and can result
in end organ damage [1]. Corticosteroids are the mainstay
of treatment with the addition of cytotoxic agents in
severe cases. Some patients are refractory to such treat-
ment and therefore management is a challenge. There is
currently limited evidence for biological agents such as
infliximab, a monoclonal anti-tumor necrosis factor-a
antibody in the treatment of multisystem sarcoidosis. Aim
of this case report is to disseminate knowledge concerning
successful treatment of multisystem sarcoidosis involving
pelvis with the use of TNF-a blockers in refractory cases.
Case presentation
33 yr old lady referred to Rheumatology with arthralgia,
myalgia, malaise, headaches, facial swelling, nausea, vomit-
ing, ear and neck pain and tingling in her fingers. Her past
medical history revealed uveitis. Subsequently she devel-
oped Right facial palsy and noted to have bilateral parotid
enlargement. Chest X-ray and CT chest confirmed exten-
sive mediastinal and bilateral hilar lymphadenopathy.
Serum ACE levels were elevated and lymphnode biopsy
confirmed Sarcoidosis.
She was started on oral prednisolone 40mg daily with
good response. However she developed erythema nodo-
sum, relapse of uveitis and repeated episodes of hyper-
calcemia needing hospital admission on trying to reduce
the dose of steroids. She complained of pain in hip
joints. MRI Pelvis showed multiple bony lesions and
bone biopsy confirmed bony involvement of sarcoidosis.
Treatment
Intavenous zolendronic acid helped with bone pain and
hypercalcemia. Commenced on azathioprine however
unable to tolerate because of headaches. Continued to
have active disease and started on infliximab and metho-
trexate. She improved on this combination treatment
and managed to reduce steroids gradually. She is on this
treatment for a year and the condition is well controlled.
Discussion
Granulomatous bone involvement has an overall inci-
dence of 1-13%. The small bones of hands and feet are
the most common localizations, while skull, knee, rib,
pelvic and sternal localizations are rarely reported [2].
The diagnosis of the sarcoid is based on the clinical pre-
sentation, radiological manifestations and histopatholo-
gical assay. Even though radiographic findings are
characteristic, could be challenging to distinguish from
bony metastasis. On literature review there are reported
case of vertebral sarcoidosis treated with anti TNF
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Figure 1 Cervical node biopsy showing Granulomas with little
lymphoid tissue
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agents, our case report suggests infliximab can be effec-
tive in treatment of refractory sarcoidosis involving pel-
vic bone [3,4].
Conclusion
This is first case reported on successful use of anti-TNF
in treatment of multisystem sarcoidosis involving pelvic
bone. There is currently limited evidence for biological
agents such as infliximab, a monoclonal anti–TNF a
antibody in the treatment of multisystem sarcoidosis [1].
Our case supports the need for randomized controlled
clinical trials of anti-TNF therapy in refractory systemic
sarcoidosis.
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Figure 2 MRI pelvis showing lesions over pelvis
Figure 3 Lesion over Rt acetabulum
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